Brooks Laboratories Limited (BROOKS) — Capital Reinvestment Ratio

Latest as of September 2025: 2.20x

Brooks Laboratories Limited (BROOKS) has a Capital Reinvestment Ratio of 2.20x as of September 2025, meaning it reinvests 2% of its operating cash flow (Rs3.19 Million) in capital expenditures (Rs7.03 Million). See cash generation quality of Brooks Laboratories Limited to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.20x
Capex / Operating Cash Flow

Operating Cash Flow

Rs3.19 Million
INR

Capital Expenditures

Rs7.03 Million
INR

Data as of

Sep 2025
Most recent filing

Brooks Laboratories Limited Capital Reinvestment Ratio (2007–2025)

This chart tracks Brooks Laboratories Limited's Capital Reinvestment Ratio across 12 annual periods.

Annual Capital Reinvestment Ratio for Brooks Laboratories Limited (2007–2025)

Year-by-year Capital Reinvestment Ratio for Brooks Laboratories Limited from 2007 to 2025. For live market cap and broader valuation context, see BROOKS market cap.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 1.06x Rs17.62 Million Rs18.59 Million ▼ -16.2%
2021 1.26x Rs44.59 Million Rs56.14 Million ▼ -31.4%
2017 1.84x Rs96.01 Million Rs176.25 Million ▼ -58.5%
2016 4.42x Rs81.19 Million Rs359.08 Million ▼ -52.9%
2015 9.40x Rs21.29 Million Rs200.06 Million ▲ +5435.0%
2014 0.17x Rs116.98 Million Rs19.86 Million ▼ -54.9%
2013 0.38x Rs53.90 Million Rs20.27 Million ▲ +61.1%
2011 0.23x Rs39.59 Million Rs9.24 Million ▼ -52.4%
2010 0.49x Rs56.91 Million Rs27.89 Million ▼ -91.3%
2009 5.66x Rs14.58 Million Rs82.59 Million ▲ +812.9%
2008 0.62x Rs20.13 Million Rs12.49 Million ▼ -98.1%
2007 32.92x Rs1.08 Million Rs35.65 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow